IGHA1 and cancer: Despite that IgA1 fused to full-length HSA showed reduced ADCC activity in vitro, this was not the case in mice given HER2-expressing cancer cells, where both the LC-fused HSA and DIII-QMP IgA1 variants showed a similar cytotoxic effect to that of unfused IgA1.